Press release
The Global Insomnia Market: Trends, Drivers, and Future Outlook
Insomnia Market:
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/2373
Key Drivers of the Insomnia Market
The growth of the insomnia market is driven by multiple factors, including:
• Rising Prevalence of Sleep Disorders: Insomnia and related conditions such as sleep apnea and restless leg syndrome are increasingly common, fueling the demand for effective treatments.
• Mental Health Issues: Depression and anxiety are closely linked to insomnia. The World Health Organization (WHO) reports that approximately 280 million people globally suffer from depression, contributing to market growth.
• Chronic Diseases and Medication Side Effects: Conditions such as cancer, cardiovascular diseases, and neurological disorders often disrupt sleep, increasing the need for insomnia treatments.
• Work-Related Stress: Irregular work schedules, night shifts, and high-pressure jobs negatively impact sleep patterns, leading to a surge in insomnia cases.
• Advancements in Non-Pharmacological Therapies: Cognitive behavioral therapy (CBT), hypnotherapy, and meditation are gaining popularity as effective non-drug treatments.
• Technological Innovations: Smart sleep-tracking devices, mobile health apps, and wearable technology provide real-time sleep analysis, improving insomnia management.
Market Segmentation
The insomnia market is categorized based on therapy type and region:
By Therapy Type
• Non-Pharmacological Therapy
• Hypnotherapy
• Cognitive Behavioral Therapy (CBT)
• Medical Devices (e.g., CPAP machines, sleep aids)
• Other Therapies (e.g., yoga, meditation)
• Pharmacological Therapy
• Prescription Sleep Aids (e.g., sedatives, orexin receptor antagonists)
• Over-the-Counter (OTC) Sleep Aids (e.g., melatonin supplements, antihistamines)
By Region
• North America: Leading the market due to high insomnia prevalence, advanced healthcare infrastructure, and work-related stress.
• Europe: Experiencing growth due to rising awareness and adoption of sleep therapies.
• Asia-Pacific: Expected to register the highest CAGR (5.5%) due to an aging population, irregular work schedules, and increasing healthcare investments.
• LAMEA (Latin America, Middle East, and Africa): Steady market growth is driven by improved healthcare access and awareness campaigns.
Emerging Trends and Opportunities
Several trends are shaping the insomnia market:
• Product Innovations: New drug formulations and non-drug alternatives continue to enter the market. Eisai Co., Ltd. launched DAYVIGO (lemborexant) in June 2021 as an effective treatment for adult insomnia.
• Growing Demand for Non-Pharmacological Solutions: Concerns over medication side effects are driving interest in alternative treatments like yoga, meditation, and digital CBT solutions.
• Expansion of Sleep Clinics and Diagnostic Centers: Specialized centers help diagnose and treat sleep disorders more effectively, improving patient outcomes.
• Wearable Sleep Technology: Devices like smartwatches and fitness trackers now offer sleep-tracking features, enabling better self-monitoring and diagnosis.
Challenges in the Insomnia Market
Despite promising growth, several challenges hinder market expansion:
• Side Effects of Medications: Dependency risks and adverse effects of long-term drug use limit widespread adoption.
• High Costs: Premium sleep aids, therapies, and diagnostic services remain unaffordable for many individuals.
• Lack of Awareness: In many developing countries, knowledge about sleep disorders and available treatments remains limited.
Key Players in the Insomnia Market
Leading companies in the global insomnia market include:
• Minerva Neurosciences Inc.
• Currax Pharmaceuticals LLC
• Eisai Co., Ltd.
• Merck & Co., Inc.
• Pfizer Inc.
• Sanofi
• Takeda Pharmaceutical Company Ltd.
• Vanda Pharmaceuticals
• Viatris (Mylan NV)
• Zydus Cadila
Future Outlook
The insomnia market is set for steady growth, fueled by increasing awareness, technological advancements, and demand for effective treatments. The rise of non-pharmacological therapies and AI-driven sleep solutions will further transform the industry. Additionally, the Asia-Pacific region is poised to become a key growth hub, providing lucrative opportunities for market players.
Key Takeaways
• The global insomnia market is projected to reach $6.3 billion by 2030.
• Major drivers include mental health issues, chronic diseases, and work-related stress.
• Non-pharmacological therapies and sleep technology are gaining traction.
• North America leads the market, while Asia-Pacific is expected to grow at the highest rate.
• Challenges include medication side effects, high costs, and limited awareness.
By addressing these challenges and leveraging emerging trends, stakeholders in the insomnia market can unlock significant growth opportunities in the coming years.
Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/2373
Contact:
David Correa
United States
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com
Follow Us on | Facebook | LinkedIn | YouTube
About Us:
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides end-to-end solutions along with information, education, advocacy, and networking resources to SMEs and early-stage start-ups to bring excellence to their processes. In addition, we offer a nurturing environment required to develop and grow businesses, including business planning; virtual support; market intelligence; acquiring resources; and getting direct access to finance, suppliers, and other experts to boost the growth of businesses and entrepreneurs.
Our bundled and hassle-free business support systems are customized to meet the needs of SME consultants and industry leaders. Moreover, our large network of skilled consultants and experts help start-ups get the business on a roll.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Global Insomnia Market: Trends, Drivers, and Future Outlook here
News-ID: 3979905 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for Insomnia
Emerging Insomnia Market Trends: Revolutionizing Insomnia Therapeutics With Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Insomnia Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the insomnia market has been on a constant rise. From $5 billion in 2024, the market is projected to expand to $5.24 billion in 2025, marking a compound annual growth rate…
Insomnia Treatment Market: Embrace Restful Nights and Recharge Your Life with Br …
Insomnia, a common sleep disorder, affects millions of people worldwide. The condition not only disrupts the sleep-wake cycle but also affects overall health and quality of life. With the increasing prevalence of insomnia, the demand for effective treatment options has surged, driving the growth of the insomnia treatment market.
Workflows are getting streamlined due to increased connectivity and quicker internet. This is an era of medical IoT, which goes on to…
Insomnia - Drug Pipeline Landscape, 2023
Insomnia is a sleep disorder that is characterized by difficulty falling asleep or staying asleep. Insomnia can be caused by a variety of factors, including stress, anxiety, depression, medications, and medical conditions. Treatment for insomnia typically includes lifestyle changes, such as avoiding caffeine and establishing a regular sleep schedule, as well as cognitive behavioral therapy and, in some cases, medication.
There are two types of insomnia primary and secondary. Primary insomnia…
Insomnia - Drug Pipeline Landscape, 2022
Insomnia is a progressive, degenerative brain disorder that attacks the brain's nerve cells, or neurons, and causes them to waste away. This disease is characterized by a slow, gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ability severe enough to interfere with daily…
Mattress Sydney – Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom.
The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioning…
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account
The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases…
